[{"url":"advising-a-company-on-the-ce-marking-of-its-first-software-medical-device-under-eu-medical-devices-legislation","entryTitle":"Advising a company on the CE marking of its first software medical device under EU medical devices legislation.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a company on the CE marking of its first software medical device under EU medical devices legislation.<\/p>"},{"url":"advising-google-llc-on-the-regulatory-requirements-and-approval-process-under-the-mdr-for-their-novel-and-first-of-its-kind-loss-of-pulse-product","entryTitle":"Advising Google LLC on the regulatory requirements and approval process under the MDR for their novel and first-of-its-kind Loss of Pulse product.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising Google LLC on the regulatory requirements and approval process under the Medical Devices Regulation (MDR) for their novel and first-of-its-kind <em>Loss of Pulse Detection <\/em>product.<\/p>"},{"url":"providing-detailed-advice-and-critical-assessment-of-a-range-of-marketing-and-advertising-communications-and-strategies-for-a-major-global-coffee-retailer-this-included-guidance-on-plastic-paper-waste-recycling","entryTitle":"Providing detailed advice and critical assessment of a range of marketing and advertising communications and strategies for a major global coffee retailer. This included guidance on plastic, paper, waste, recycling","representativeMatterTitle":"","representativeMatterContent":"<p>Providing detailed advice and critical assessment of a range of marketing and advertising communications and strategies for a major global coffee retailer. This included guidance on plastic, paper, waste, recycling, and other general environmental and sustainability claims.<\/p>"},{"url":"providing-advice-and-training-to-a-global-healthcare-company-on-advertising-for-connected-medical-devices-to-be-marketed-for-retail-purposes","entryTitle":"Providing advice and training to a global healthcare company on advertising for connected medical devices to be marketed for retail purposes.","representativeMatterTitle":"","representativeMatterContent":"<p>Providing advice and training to a global healthcare company on advertising for connected medical devices to be marketed for retail purposes.<\/p>"},{"url":"advising-a-baby-monitor-manufacturer","entryTitle":"Advising a baby monitor manufacturer","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a baby monitor manufacturer on their engagement with the Health Products Regulated Authority (HPRA) concerning product classification and potential withdrawal of a product from EU markets.<\/p>"},{"url":"advising-fitbit-llc-on-the-ce-marking-of-its-software-medical-device-portfolio-ecg-and-subsequent-devices-under-eu-medical-devices-legislation","entryTitle":"Advising Fitbit LLC on the CE marking of its software medical device portfolio, ECG, and subsequent devices under EU medical devices legislation.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising Fitbit LLC (now Google LLC) on the CE marking of its software medical device portfolio under EU medical devices legislation.<\/p>"},{"url":"offering-advice-and-training-for-a-global-healthcare-company-on-advertising-for-connected-medical-devices-to-be-marketed-for-retail-purposes","entryTitle":"Offering advice and training for a global healthcare company on advertising for connected medical devices to be marketed for retail purposes.","representativeMatterTitle":"","representativeMatterContent":"<p>Offering advice and training for a global healthcare company on advertising for connected medical devices to be marketed for retail purposes.<\/p>"},{"url":"advising-letsgetchecked-on-its-regulatory-obligations-under-the-ivdr-and-regarding-its-telemedicine-services","entryTitle":"Advising LetsGetChecked on its regulatory obligations under the IVDR and regarding its telemedicine services.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising LetsGetChecked on its regulatory obligations under the IVDR and its telemedicine services.<\/p>"},{"url":"advising-google-llc-on-the-development-of-a-number-of-software-medical-devices-including-its-groundbreaking-loss-of-pulse-detection-feature","entryTitle":"Advising Google LLC on the development of a number of software medical devices including its groundbreaking Loss of Pulse Detection feature.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising Google LLC on the development of a number of software medical devices including its groundbreaking <em>Loss of Pulse Detection <\/em>feature.<\/p>"},{"url":"advising-a-global-baby-monitoring-manufacturer-engaging-with-eu-health-product-regulators-concerning-product-classification-and-related-corrective-actions-this-included-the-potential-withdrawal-of-a-baby-monitor-product-from-eu-mark","entryTitle":"Advising a global baby monitoring manufacturer engaging with EU health product regulators concerning product classification and related corrective actions. This included the potential withdrawal of a baby monitor product from EU markets.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global baby monitoring manufacturer engaging with EU health product regulators concerning product classification and related corrective actions. This included the potential withdrawal of a baby monitor product from EU markets.<\/p>"},{"url":"advising-a-global-manufacturer-of-cgm-sensors-on-marketing-and-advertising-rules-for-medical-devices-in-ireland","entryTitle":"Advising a global manufacturer of CGM sensors on marketing and advertising rules for medical devices in Ireland.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global manufacturer of CGM sensors on marketing and advertising rules for medical devices in Ireland.<\/p>"},{"url":"advising-a-top-10-fortune-100-company-on-medical-device-regulatory-requirements-under-the-uk-mdr","entryTitle":"Advising a top 10 Fortune 100 company on medical device regulatory requirements under the UK MDR.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a top 10 Fortune 100 company on medical device regulatory requirements under the UK Medical Devices Regulation (MDR). This included advising on a large corporate merger and the drafting and implementation of quality agreements.<\/p>"},{"url":"advising-a-global-technology-company-on-the-classification-of-hearing-assistance-products-including-issues-relating-to-data-privacy-product-classification-and-reimbursement","entryTitle":"Advising a global technology company on the classification of hearing assistance products including issues relating to data privacy, product classification and reimbursement.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global technology company on the classification of hearing assistance products including issues relating to data privacy, product classification and reimbursement.<\/p>"},{"url":"advising-a-global-technology-company-on-a-research-collaboration-agreement-with-universities-relating-to-the-use-of-wearable-devices","entryTitle":"Advising a global technology company on a research collaboration agreement with universities relating to the use of wearable devices.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global technology company on a research collaboration agreement with universities relating to the use of wearable devices.<\/p>"},{"url":"advising-a-global-healthcare-company-on-the-classification-of-its-portfolio-of-software-medical-device-applications-in-the-eu-and-the-uk-also-provided-guidance-regarding-transition-planning-following-brexit-and-the-coming-into-effec","entryTitle":"Advising a global healthcare company on the classification of its portfolio of software medical device applications in the EU and the UK. Also provided guidance regarding transition planning following Brexit and the coming into effect of the EU Medical De","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global healthcare company on the classification of its portfolio of software medical device applications in the EU and the UK. Also provided guidance regarding transition planning following Brexit and the coming into effect of the EU Medical Device Regulation.<\/p>"},{"url":"backend-title","entryTitle":"Backend Title","representativeMatterTitle":"Client name","representativeMatterContent":"<p>Advised on X.<\/p>"},{"url":"acting-for-novartis-in-patent-infringement-and-revocation-proceedings-regarding-the-sale-of-taltz-in-ireland-including-a-competition-law-counterclaim","entryTitle":"Acting for Novartis in patent infringement and revocation proceedings regarding the sale of Taltz\u00ae in Ireland., including a competition law counterclaim.\u202f","representativeMatterTitle":"","representativeMatterContent":"<p>Acting for Novartis in patent infringement and revocation proceedings regarding the sale of Taltz\u00ae in Ireland, including a competition law counterclaim.<\/p>"},{"url":"acting-for-neuraxpharm-in-the-defence-of-patent-infringement-proceedings-and-the-prosecution-of-an-invalidity-counterclaim-related-to-the-launch-of-a-generic-ms-treatment-on-the-irish-market","entryTitle":"Acting for Neuraxpharm in the defence of patent infringement proceedings and the prosecution of an invalidity counterclaim related to the launch of a generic MS treatment on the Irish market.\u202f","representativeMatterTitle":"","representativeMatterContent":"<p>Acting for Neuraxpharm in the defence of patent infringement proceedings and the prosecution of an invalidity counterclaim related to the launch of a generic MS treatment on the Irish market.<\/p>"},{"url":"acting-for-fresenius-in-patent-infringement-proceedings-regarding-the-launch-of-amgevita-by-amgen-a-biosimilar-of-humira-which-is-currently-the-worlds-top-selling-drug","entryTitle":"Acting for Fresenius in patent infringement proceedings regarding the launch of Amgevita\u00ae by Amgen, a biosimilar of Humira\u00ae, which is currently the world\u2019s top selling drug.\u202f","representativeMatterTitle":"","representativeMatterContent":"<p>Acting for Fresenius in patent infringement proceedings regarding the launch of Amgevita\u00ae by Amgen, a biosimilar of Humira\u00ae, which is currently the world\u2019s top selling drug.<\/p>"},{"url":"acting-for-celltrion-in-the-defence-of-patent-infringement-proceedings-relating-to-the-launch-of-truxima-a-biosimilar-of-the-cancer-medication-rituximab","entryTitle":"Acting for Celltrion in the defence of patent infringement proceedings relating to the launch of Truxima, a biosimilar of the cancer medication rituximab.\u202f","representativeMatterTitle":"","representativeMatterContent":"<p>Acting for Celltrion in the defence of patent infringement proceedings relating to the launch of Truxima, a biosimilar of the cancer medication rituximab.<\/p>"},{"url":"acting-for-teva-in-spc-and-patent-revocation-proceedings-regarding-the-product-tiotropium-bromide-and-capsule-materials-for-the-treatment-for-respiratory-disorders","entryTitle":"Acting for Teva in SPC and patent revocation proceedings regarding the product Tiotropium Bromide and capsule materials for the treatment for respiratory disorders.\u202f","representativeMatterTitle":"","representativeMatterContent":"<p>Acting for Teva in SPC and patent revocation proceedings regarding the product Tiotropium Bromide and capsule materials for the treatment of respiratory disorders.<\/p>"},{"url":"acting-for-teva-in-patent-infringement-and-invalidity-proceedings-relating-to-the-launch-of-a-generic-version-of-truvada-one-of-the-most-successful-anti-retroviral-products","entryTitle":"Acting for Teva in patent infringement and invalidity proceedings relating to the launch of a generic version of Truvada\u00ae, one of the most successful anti-retroviral products.\u202f","representativeMatterTitle":"","representativeMatterContent":"<p>Acting for Teva in patent infringement and invalidity proceedings relating to the launch of a generic version of Truvada\u00ae, one of the most successful anti-retroviral products.<\/p>"},{"url":"acting-for-\u00edpek-kagit-in-patent-infringement-and-revocation-proceedings-relating-to-tissue-dispensers","entryTitle":"Acting for \u00cdpek Kagit in patent infringement and revocation proceedings relating to tissue dispensers.\u202f","representativeMatterTitle":"","representativeMatterContent":"<p>Acting for \u00cdpek Kagit in patent infringement and revocation proceedings relating to tissue dispensers.<\/p>"},{"url":"advising-roebuck-food-group-on-ip-aspects-of-its-acquisition-of-glasport-bio-limited-and-glasport-rumen-tech-limited-including-patent-licensing-relating-to-methane-reduction-for-animal-feeds-and-manure","entryTitle":"Advising Roebuck Food Group on IP aspects of its acquisition of GlasPort Bio Limited and GlasPort Rumen Tech Limited, including patent licensing relating to methane reduction for animal feeds and manure","representativeMatterTitle":"","representativeMatterContent":"<p>Advising Roebuck Food Group on IP aspects of its acquisition of GlasPort Bio Limited and GlasPort Rumen Tech Limited, including patent licensing relating to methane reduction for animal feeds and manure<\/p>"},{"url":"advising-an-innovative-medtech-company-on-a-range-of-issues-relating-to-the-ownership-and-restructuring-of-intellectual-property-including-patents-in-preparation-for-the-sale-of-the-business","entryTitle":"Advising an innovative MedTech company on a range of issues relating to the ownership and restructuring of intellectual property, including patents, in preparation for the sale of the business.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising an innovative medtech company on a range of issues relating to the ownership and restructuring of intellectual property, including patents, in preparation for the sale of the business.<\/p>"},{"url":"advising-bertelsmann-on-its-acquisition-of-medicines-ie-irelands-official-source-of-information-on-authorised-medicines","entryTitle":"Advising Bertelsmann on its acquisition of Medicines.ie, Ireland\u2019s official source of information on authorised medicines.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising Bertelsmann on its acquisition of Medicines.ie, Ireland\u2019s official source of information on authorised medicines.<\/p>"},{"url":"advising-endotronix-inc-on-its-high-profile-merger-with-fortune-500-company-edwards-life-sciences","entryTitle":"Advising Endotronix Inc. on its high profile merger with Fortune 500 company, Edwards Lifesciences.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising Endotronix Inc. on its high profile merger with Fortune 500 company, Edwards Lifesciences.<\/p>"},{"url":"advising-vimian-group-a-swedish-animal-health-company-on-its-acquisition-of-im3-dental-limited","entryTitle":"Advising Vimian Group, a Swedish animal health company, on its acquisition of iM3 Dental Limited.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising Vimian Group, a Swedish animal health company, on its acquisition of iM3 Dental Limited.<\/p>"},{"url":"acting-for-biosynth-on-its-acquisition-of-the-fitzgerald-industries-life-sciences-supply-business-from-trinity-biotech","entryTitle":"Acting for Biosynth on its acquisition of the life sciences supply business Fitzgerald Industries from Trinity Biotech.","representativeMatterTitle":"","representativeMatterContent":"<p>Acting for Biosynth on its acquisition of the Fitzgerald Industries life sciences supply business from Trinity Biotech.<\/p>"},{"url":"advising-elkstone-on-investments-into-medtech-businesses-such-as-cro\u00edvalve-and-hidramed-solutions","entryTitle":"Advising Elkstone on investments into medtech businesses such as Cro\u00edValve and HidraMed Solutions.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising Elkstone on investments into medtech businesses such as Cro\u00edValve and HidraMed Solutions.<\/p>"},{"url":"advising-a-global-testing-laboratory-on-all-data-protection-obligations-related-to-the-conduct-of-clinical-trials-anonymisation-and-pseudonymisation-in-the-context-of-health-research","entryTitle":"Advising a global testing laboratory on all data protection obligations related to the conduct of clinical trials, anonymisation and pseudonymisation in the context of health research.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global testing laboratory on all data protection obligations related to the conduct of clinical trials, anonymisation and pseudonymisation in the context of health research.<\/p>"},{"url":"advising-fitbit-llc-now-google-llc-on-all-of-its-data-protection-obligations-regarding-its-services-and-products","entryTitle":"Advising Fitbit LLC (now Google LLC) on all of its data protection obligations regarding its services and products.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising Fitbit LLC (now Google LLC) on all of its data protection obligations regarding its services and products.<\/p>"},{"url":"advising-a-global-technology-company-on-data-protection-obligations-arising-from-the-use-of-a-mental-health-support-chat-bot","entryTitle":"Advising a global technology company on data protection obligations arising from the use of a mental health support chat bot.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global technology company on data protection obligations arising from the use of a mental health support chat bot.<\/p>"},{"url":"advising-a-global-technology-company-on-the-consents-required-and-general-data-protection-compliance-required-in-connection-with-health-insights-and-recommendations-from-its-wearable-devices","entryTitle":"Advising a global technology company on the consents required and general data protection compliance required in connection with health insights and recommendations from its wearable devices.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global technology company on the consents required and general data protection compliance required in connection with health insights and recommendations from its wearable devices.<\/p>"},{"url":"advising-a-national-hospital-group-on-its-data-protection-obligations-in-the-context-of-clinical-trial-agreements","entryTitle":"Advising a national hospital group on its data protection obligations in the context of clinical trial agreements.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a national hospital group on its data protection obligations in the context of clinical trial agreements.<\/p>"},{"url":"advising-an-international-covid-19-testing-company-on-its-data-privacy-obligations-including-drafting-their-privacy-policy-and-advising-on-the-collection-of-consents","entryTitle":"Advising an international COVID-19 testing company on its data privacy obligations, including drafting their privacy policy and advising on the collection of consents.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising an international COVID-19 testing company on its data privacy obligations, including drafting their privacy policy and advising on the collection of consents.<\/p>"},{"url":"advising-a-global-pharmaceutical-company-on-the-data-privacy-and-commercial-aspects-of-providing-a-third-party-patient-assistance-app-for-use-with-one-of-its-medicines","entryTitle":"Advising a global pharmaceutical company on the data privacy and commercial aspects of providing a third-party patient assistance app for use with one of its medicines.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global pharmaceutical company on the data privacy and commercial aspects of providing a third-party patient assistance app for use with one of its medicines.<\/p>"},{"url":"preparing-a-data-protection-impact-assessment-for-a-clinical-stage-pharmaceutical-company-concerning-the-processing-of-personal-data-in-the-context-of-a-clinical-trial","entryTitle":"Preparing a data protection impact assessment for a clinical-stage pharmaceutical company concerning the processing of personal data in the context of a clinical trial.","representativeMatterTitle":"","representativeMatterContent":"<p>Preparing a data protection impact assessment for a clinical-stage pharmaceutical company concerning the processing of personal data in the context of a clinical trial. <br \/><\/p>"},{"url":"advising-a-global-pharmaceutical-company-on-health-care-professional-consent-in-the-context-of-direct-marketing","entryTitle":"Advising a global pharmaceutical company on health care professional consent in the context of direct marketing.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global pharmaceutical company on health care professional consent in the context of direct marketing.<\/p>"},{"url":"advising-a-global-clinical-trial-stage-biopharmaceutical-company-on-the-completion-of-a-statement-of-compliance-regarding-data-protection-compliance-prior-to-submission-to-the-national-research-ethics-committee","entryTitle":"Advising a global clinical trial stage biopharmaceutical company on the completion of a Statement of Compliance regarding data protection compliance prior to submission to the National Research Ethics Committee.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global clinical trial stage biopharmaceutical company on the completion of a Statement of Compliance regarding data protection compliance prior to submission to the National Research Ethics Committee.<\/p>"},{"url":"acting-as-eu-regulatory-counsel-to-letsgetchecked-on-all-areas-of-regulatory-compliance-particularly-under-the-ivdr-regarding-the-provision-of-their-at-home-test-kits-and-services","entryTitle":"Advising LetsGetChecked on all areas of EU regulatory compliance, particularly under the IVDR, regarding the provision of their at-home test kits and services.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising LetsGetChecked on all areas of EU regulatory compliance, particularly under the IVDR, regarding the provision of their at-home test kits and services.<\/p>"},{"url":"provided-eu-product-regulatory-advice-to-google-llc-during-the-development-and-launch-of-its-loss-of-pulse-detection-device","entryTitle":"Provided EU product regulatory advice to Google LLC during the development and launch of its Loss of Pulse Detection device.","representativeMatterTitle":"","representativeMatterContent":"<p>Provided EU product regulatory advice to Google LLC during the development and launch of its <em>Loss of Pulse Detection<\/em> device.<\/p>"},{"url":"acting-as-eu-regulatory-counsel-to-fitbit-llc-now-google-llc-supporting-eu-regulatory-compliance-programmes-for-eu-consumer-products-and-medical-devices-frameworks","entryTitle":"Acting as EU regulatory counsel to Fitbit LLC (now Google LLC) supporting EU regulatory compliance programmes for EU consumer products and medical devices frameworks.","representativeMatterTitle":"","representativeMatterContent":"<p>Acting as EU regulatory counsel to Fitbit LLC (now Google LLC) supporting EU regulatory compliance programmes for EU consumer products and medical devices frameworks.<\/p>"},{"url":"acting-as-eu-regulatory-counsel-to-a-global-diabetes-treatment-company-our-work-involves-providing-support-on-eu-regulatory-requirements-for-various-software-medical-devices-connected-insulin-pump-devices-and-related-accessories","entryTitle":"Acting as EU regulatory counsel to a global diabetes treatment company. Our work involves providing support on EU regulatory requirements for various software medical devices, connected insulin pump devices and related accessories.","representativeMatterTitle":"","representativeMatterContent":"<p>Acting as EU regulatory counsel to a global diabetes treatment company. Our work involves providing support on EU regulatory requirements for various software medical devices, connected insulin pump devices and related accessories.<\/p>"},{"url":"advising-nest-labs-now-google-llc-on-compliance-with-eu-regulatory-frameworks-applicable-to-various-general-consumer-and-health-wellness-products","entryTitle":"Advising Nest Labs (now Google LLC) on compliance with EU regulatory frameworks applicable to various general consumer and health & wellness products.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising Nest Labs (now Google LLC) on compliance with EU regulatory frameworks applicable to various general consumer and health & wellness products.<\/p>"},{"url":"advising-a-fortune-100-healthcare-company-on-the-classification-of-its-portfolio-of-software-medical-device-applications-in-the-eu-and-the-uk","entryTitle":"Advising a Fortune 100 healthcare company on the classification of its portfolio of software medical device applications in the EU and the UK.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a Fortune 100 healthcare company on the classification of its portfolio of software medical device applications in the EU and the UK.<\/p>"},{"url":"advising-a-fortune-100-healthcare-company-on-their-qms-structure-and-delegation-of-certain-compliance-activities-under-a-quality-agreement","entryTitle":"Advising a Fortune 100 healthcare company on their QMS structure and delegation of certain compliance activities under a quality agreement.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a Fortune 100 healthcare company on their QMS structure and delegation of certain compliance activities under a quality agreement.<\/p>"},{"url":"advising-for-a-global-telemedicine-business-on-the-application-of-eu-prescription-and-control-of-supply-requirements-to-its-operating-model","entryTitle":"Advising a global telemedicine business on the application of EU prescription and control of supply requirements to its operating model.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global telemedicine business on the application of EU prescription and control of supply requirements to its operating model.<\/p>"},{"url":"advising-a-global-pharmaceutical-company-on-its-obligations-around-interactions-with-hcps-in-ireland-as-part-of-planned-promotional-activities","entryTitle":"Advising a global pharmaceutical company on its obligations around interactions with HCPs in Ireland as part of planned promotional activities.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global pharmaceutical company on its obligations around interactions with HCPs in Ireland as part of planned promotional activities.<\/p>"},{"url":"advising-a-us-manufacturer-of-a-surgical-device-responding-to-an-investigation-by-the-health-products-regulatory-authority-hpra","entryTitle":"Advising a US manufacturer of a surgical device responding to an investigation by the Health Products Regulatory Authority (HPRA).","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a US manufacturer of a surgical device responding to an investigation by the Health Products Regulatory Authority (HPRA).<\/p>"},{"url":"advising-a-manufacturer-of-cbd-products-responding-to-a-regulatory-investigation-and-enforcement-measures-carried-out-by-the-food-safety-authority-of-ireland-fsai","entryTitle":"Advising a manufacturer of CBD products responding to a regulatory investigation and enforcement measures carried out by the Food Safety Authority of Ireland (FSAI).","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a manufacturer of CBD products responding to a regulatory investigation and enforcement measures carried out by the Food Safety Authority of Ireland (FSAI).<\/p>"},{"url":"representing-a-global-manufacturer-of-implantable-devices-in-the-defence-of-multiple-product-liability-claims","entryTitle":"Representing a global manufacturer of implantable devices in the defence of multiple product liability claims.","representativeMatterTitle":"","representativeMatterContent":"<p>Representing a global manufacturer of implantable devices in the defence of multiple product liability claims.<\/p>"},{"url":"acting-for-a-leading-international-distributor-of-medical-products-in-the-defence-of-multiple-claims-arising-from-allegedly-defective-intra-ocular-lenses","entryTitle":"Acting for a leading international distributor of medical products in the defence of multiple claims arising from allegedly defective intra-ocular lenses","representativeMatterTitle":"","representativeMatterContent":"<p>Acting for a leading international distributor of medical products in the defence of multiple claims arising from allegedly defective intra-ocular lenses.<\/p>"},{"url":"advising-a-global-software-company-on-product-liability-issues-arising-from-a-health-related-app","entryTitle":"Advising a global software company on product liability issues arising from a health-related app.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global software company on product liability issues arising from a health-related app. <\/p>"},{"url":"representing-the-manufacturer-of-breast-implants-in-the-defence-of-high-volume-product-liability-litigation-in-ireland-which-formed-part-of-a-pan-eu-litigation","entryTitle":"Representing a manufacturer of breast implants in the defence of high volume product liability litigation in Ireland which formed part of a pan-EU litigation.","representativeMatterTitle":"","representativeMatterContent":"<p>Representing a manufacturer of breast implants in the defence of high volume product liability litigation in Ireland which formed part of a pan-EU litigation.<\/p>"},{"url":"acting-for-the-health-service-executive-in-the-context-of-claims-arising-from-the-depuy-hip-implant-recall-on-instruction-from-the-state-claims-agency","entryTitle":"Acting for the Health Service Executive in the context of claims arising from the DePuy hip implant recall, on instruction from the State Claims Agency.","representativeMatterTitle":"","representativeMatterContent":"<p>Acting for the Health Service Executive in the context of claims arising from the DePuy hip implant recall, on instruction from the State Claims Agency.<\/p>"},{"url":"providing-eu-regulatory-advice-to-a-global-pharmaceutical-company-on-the-application-of-the-ai-act-to-the-regulation-of-drug-development-and-clinical-research","entryTitle":"Providing EU regulatory advice to a global pharmaceutical company on the application of the AI Act to the regulation of drug development and clinical research.","representativeMatterTitle":"","representativeMatterContent":"<p>Providing EU regulatory advice to a global pharmaceutical company on the application of the AI Act to the regulation of drug development and clinical research.<\/p>"},{"url":"advising-some-of-the-worlds-leading-genai-providers-on-the-application-of-eu-medical-device-law-to-the-general-purpose-ai-systems","entryTitle":"Advising some of the world\u2019s leading GenAI providers on the application of EU medical device law to the general-purpose AI systems.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising some of the world\u2019s leading GenAI providers on the application of EU medical device law to their general-purpose AI systems.<\/p>"},{"url":"providing-eu-regulatory-advice-to-a-global-consumer-electronics-and-fitness-company-on-the-application-of-the-ai-act-to-its-health-products","entryTitle":"Providing EU regulatory advice to a global consumer electronics and fitness company on the application of the AI Act to its health products.","representativeMatterTitle":"","representativeMatterContent":"<p>Providing EU regulatory advice to a global consumer electronics and fitness company on the application of the AI Act to its health products.<\/p>"},{"url":"eu-regulatory-advice-to-a-fortune-100-global-healthcare-company-on-the-application-of-the-ai-act-to-their-products","entryTitle":"Providing EU regulatory advice to a Fortune 100 Global healthcare company on the application of the AI Act to their products","representativeMatterTitle":"","representativeMatterContent":"<p>Providing EU regulatory advice to a Fortune 100 Global healthcare company on the application of the AI Act to their products.<\/p>"},{"url":"advice-to-a-provider-of-a-conversational-ai-assistant-on-the-impact-of-eu-medical-device-law-on-its-services","entryTitle":"Advising a provider of a conversational AI assistant on the impact of EU medical device law on its services.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a provider of a conversational AI assistant on the impact of EU medical device law on its services.<\/p>"},{"url":"advising-fitbit-llc-now-google-llc-on-a-clinical-research-collaboration-agreement","entryTitle":"Advising Fitbit LLC (now Google LLC) on a clinical research collaboration agreement.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising Fitbit LLC (now Google LLC) on a clinical research collaboration agreement.<\/p>"},{"url":"advising-a-fortune-100-company-on-qms-compliance-and-drafting-related-quality-agreements","entryTitle":"Advising a Fortune 100 company on QMS compliance and drafting related quality agreements.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a Fortune 100 company on QMS compliance and drafting related quality agreements.<\/p>"},{"url":"advising-a-global-supplier-of-ivds-on-distribution-agreements","entryTitle":"Advising a global supplier of IVDs on distribution agreements.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global supplier of IVDs on distribution agreements.<\/p>"},{"url":"advising-a-global-pharmaceutical-company-on-the-commercial-relationship-between-an-app-provider-and-a-patient-support-programme","entryTitle":"Advising a global pharmaceutical company on the commercial relationship between an app provider and a patient support programme.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global pharmaceutical company on the commercial relationship between an app provider and a patient support programme.<\/p>"},{"url":"advising-an-irish-hospital-on-the-drafting-and-negotiation-of-a-contract-for-the-roll-out-of-a-cloud-based-electronic-health-records-solution","entryTitle":"Advising an Irish hospital on the drafting and negotiation of a contract for the roll out of a cloud based electronic health records solution.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising an Irish hospital on the drafting and negotiation of a contract for the roll out of a cloud based electronic health records solution.<\/p>"},{"url":"advising-an-irish-hospital-on-the-drafting-of-a-clinical-trial-agreement","entryTitle":"Advising an Irish hospital on the drafting of a clinical trial agreement.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising an Irish hospital on the drafting of a clinical trial agreement.<br \/><\/p>"},{"url":"advising-west-pharmaceuticals-on-the-lease-and-significant-fit-out-of-its-properties-at-damastown-industrial-estate-and-also-in-connection-with-its-acquisition-of-adjoining-lands","entryTitle":"Advising West Pharmaceuticals on the lease and significant fit-out of its properties at Damastown Industrial Estate, and also in connection with its acquisition of adjoining lands.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising West Pharmaceuticals on the lease and significant fit-out of its properties at Damastown Industrial Estate, and also in connection with its acquisition of adjoining lands.<\/p>"},{"url":"advising-virtus-health-on-its-acquisition-of-a-70-interest-in-irelands-largest-ivf-provider-sims-ivf-for-15-49-million-and-of-the-hari-unit-of-the-rotunda-hospital","entryTitle":"Advising Virtus Health on its acquisition of a 70% interest in Ireland\u2019s largest IVF provider, SIMS IVF, for \u20ac15.49 million, and of the HARI Unit of the Rotunda Hospital.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising Virtus Health on its acquisition of a 70% interest in Ireland\u2019s largest IVF provider, SIMS IVF, for \u20ac15.49 million, and of the HARI Unit of the Rotunda Hospital.<\/p>"},{"url":"advised-irish-life-on-the-acquisition-design-and-construction-of-logistics-facilities-at-vantage-business-park-aerodrome-business-park-and-airport-business-park","entryTitle":"Advised Irish Life on the acquisition, design and construction of logistics facilities at Vantage Business Park, Aerodrome Business Park and Airport Business Park.","representativeMatterTitle":"","representativeMatterContent":"<p>Advised Irish Life on the acquisition, design and construction of logistics facilities at Vantage Business Park, Aerodrome Business Park and Airport Business Park.<\/p>"},{"url":"advised-rohan-holdings-on-the-acquisition-of-industrial-sites-leases-to-several-industrial-tenants-and-development-and-the-sale-of-industrial-premises","entryTitle":"Advised Rohan Holdings on the acquisition of industrial sites, leases to several industrial tenants and development, and the sale of industrial premises.","representativeMatterTitle":"","representativeMatterContent":"<p>Advised Rohan Holdings on the acquisition of industrial sites, leases to several industrial tenants and development, and the sale of industrial premises.<\/p>"},{"url":"advised-db-schenker-on-site-acquisition-and-the-procurement-design-and-construction-of-a-purpose-built-logistics-facility-within-the-liffey-business-campus-in-kildare","entryTitle":"Advised DB Schenker on site acquisition and the procurement, design and construction of a purpose-built logistics facility within the Liffey Business Campus in Kildare.","representativeMatterTitle":"","representativeMatterContent":"<p>Advised DB Schenker on site acquisition and the procurement, design and construction of a purpose-built logistics facility within the Liffey Business Campus in Kildare.<\/p>"},{"url":"advising-biohaven-on-entering-into-a-collaboration-agreement-with-pfizer-and-on-the-later-11-6-billion-sale-of-biohaven-pharmaceutical-ireland-dac-to-pfizer","entryTitle":"Advising Biohaven on entering into a collaboration agreement with Pfizer and on the later $11.6 billion sale of Biohaven Pharmaceutical Ireland DAC to Pfizer.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising Biohaven on entering into a collaboration agreement with Pfizer, and on the later $11.6 billion sale of Biohaven Pharmaceutical Ireland DAC to Pfizer.<\/p>"},{"url":"advising-an-international-energy-and-chemicals-group-on-the-implications-for-its-reach-registration-as-part-of-a-tax-restructuring-process","entryTitle":"Advising an international energy and chemicals group on the implications for its REACH registration as part of a tax restructuring process.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising an international energy and chemicals group on the implications for its REACH registration as part of a tax restructuring process.<\/p>"},{"url":"acting-for-biosynth-international-inc-a-kkr-portfolio-company-on-its-circa-30-million-purchase-of-benen-trading-limited-and-fitzgerald-industries-from-trinity-biotech","entryTitle":"Acting for Biosynth International Inc., a KKR portfolio company, on its circa $30 million purchase of Benen Trading Limited and Fitzgerald Industries from Trinity Biotech.","representativeMatterTitle":"","representativeMatterContent":"<p>Acting for Biosynth International Inc., a KKR portfolio company, on its circa $30 million purchase of Benen Trading Limited and Fitzgerald Industries from Trinity Biotech.<\/p>"},{"url":"advising-a-nyse-listed-clinical-stage-biopharmaceutical-company-on-its-global-ip-restructuring-and-commercialisation-project","entryTitle":"Advising a NYSE listed clinical-stage biopharmaceutical company on its global IP restructuring and commercialisation project.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a NYSE listed clinical-stage biopharmaceutical company on its global IP restructuring and commercialisation project.<\/p>"},{"url":"advising-a-global-medtech-company-on-restructuring-of-corporate-structure-and-intragroup-arrangements-to-achieve-additional-efficiencies-sand-minimise-tax-leakage","entryTitle":"Advising a global medtech company on restructuring of corporate structure and intragroup arrangements to achieve additional efficiencies sand minimise tax leakage.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global medtech company on restructuring of corporate structure and intragroup arrangements to achieve additional efficiencies and minimise tax leakage.<\/p>"},{"url":"advising-a-number-of-multinational-life-sciences-companies-on-the-availability-of-research-and-development-tax-credits-and-the-irish-patent-box-regime-for-intellectual-property-development-and-exploitation-activities","entryTitle":"Advising a number of multinational life sciences companies on the availability of research and development tax credits and the Irish Patent Box regime for intellectual property development and exploitation activities.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a number of multinational life sciences companies on the availability of research and development tax credits and the Irish Patent Box regime for intellectual property development and exploitation activities.<\/p>"},{"url":"advising-a-global-medtech-company-on-the-implementation-of-their-transfer-pricing-policies-including-drafting-of-an-intragroup-framework-and-operating-agreements","entryTitle":"Advising a global medtech company on the implementation of their transfer pricing policies including drafting of an intragroup framework and operating agreements.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global medtech company on the implementation of their transfer pricing policies including drafting of an intragroup framework and operating agreements.<\/p>"},{"url":"advising-comar-holdings-llc-a-custom-medical-devices-supplier-on-its-acquisition-of-the-entire-issued-share-capital-of-the-pharmaceutical-injection-moulded-products-supplier-automatic-plastics-ltd","entryTitle":"Advising Comar Holdings LLC, a custom medical devices supplier, on its acquisition of the entire issued share capital of the pharmaceutical injection moulded products supplier Automatic Plastics Ltd.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising Comar Holdings LLC, a custom medical devices supplier, on its acquisition of the entire issued share capital of the pharmaceutical injection moulded products supplier Automatic Plastics Ltd.<\/p>"},{"url":"representing-a-global-manufacturing-of-breast-implants-in-the-defence-of-irish-product-liability-litigation-proceedings","entryTitle":"Representing a global manufacturer of breast implants in the defence of Irish product liability litigation proceedings.","representativeMatterTitle":"","representativeMatterContent":"<p>Representing a global manufacturer of breast implants in the defence of Irish product liability litigation proceedings.<\/p>"},{"url":"exclusive-irish-counsel-to-a-global-medical-device-manufacturer-on-the-procurement-and-development-of-numerous-substantial-manufacturing-and-cleanroom-facilities-our-work-also-covers-equipment-procurement-projects-and-fit-out-projec","entryTitle":"Exclusive Irish counsel to a global medical device manufacturer on the procurement and development of numerous substantial manufacturing and cleanroom facilities. Our work also covers equipment procurement projects and fit-out projects with a combined dev","representativeMatterTitle":"","representativeMatterContent":"<p>Exclusive Irish counsel to a global medical device manufacturer on the procurement and development of numerous substantial manufacturing and cleanroom facilities. Our work also covers equipment procurement projects and fit-out projects with a combined development value exceeding \u20ac700 million. <\/p>"},{"url":"advising-a-global-pharmaceutical-company-on-extensions-to-its-manufacturing-facilities-new-cleanroom-facilities-and-new-offices-across-ireland","entryTitle":"Advising a global pharmaceutical company on extensions to its manufacturing facilities, new cleanroom facilities and new offices across Ireland.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global pharmaceutical company on extensions to its manufacturing facilities, new cleanroom facilities and new offices across Ireland. <br \/><\/p>"},{"url":"advising-a-global-manufacturer-in-the-pharmaceutical-industry-on-the-design-and-construction-of-new-plant-facilities-in-dublin-including-advice-on-issues-relating-to-disputes-arising-under-those-contracts","entryTitle":"Advising a global manufacturer in the pharmaceutical industry on the design and construction of new plant facilities in Dublin, including advice on issues relating to disputes arising under those contracts.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global manufacturer in the pharmaceutical industry on the design and construction of new plant facilities in Dublin, including advice on issues relating to disputes arising under those contracts.<\/p>"},{"url":"acting-for-a-global-life-science-client-on-the-procurement-of-new-equipment-plant-facilities-and-new-infrastructure","entryTitle":"Acting for a global life science client on the procurement of new equipment, plant facilities and new infrastructure.","representativeMatterTitle":"","representativeMatterContent":"<p>Acting for a global life science client on the procurement of new equipment, plant facilities and new infrastructure.<\/p>"},{"url":"advising-a-global-engineering-contractor-on-the-procurement-and-construction-of-a-number-of-pharmaceutical-technology-manufacturing-and-renewable-energy-plants-in-ireland-with-a-total-development-value-exceeding-10-billion","entryTitle":"Advising a global engineering contractor on the procurement and construction of a number of pharmaceutical, technology, manufacturing and renewable energy plants in Ireland, with a total development value exceeding \u20ac10 billion.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global engineering contractor on the procurement and construction of a number of pharmaceutical, technology, manufacturing and renewable energy plants in Ireland, with a total development value exceeding \u20ac10 billion.<\/p>"},{"url":"acting-on-behalf-of-quest-diagnostics-inc-a-us-fortune-500-company-in-defence-of-a-number-of-fast-tracked-professional-negligence-proceedings","entryTitle":"Acting on behalf of Quest Diagnostics Inc, a US Fortune 500 company, in defence of a number of fast-tracked professional negligence proceedings.","representativeMatterTitle":"","representativeMatterContent":"<p>Acting on behalf of Quest Diagnostics Inc, a US Fortune 500 company, in defence of a number of fast-tracked professional negligence proceedings.<\/p>"},{"url":"advised-the-state-claims-agency-in-the-defence-of-a-wide-range-of-negligence-claims-against-public-hospitals-health-care-providers-and-representing-healthcare-professionals-at-coroners-inquests","entryTitle":"Advising the State Claims Agency in the defence of a wide range of negligence claims against public hospitals\/health care providers and representing healthcare professionals at Coroners\u2019 Inquests.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising the State Claims Agency in the defence of a wide range of negligence claims against public hospitals\/health care providers and representing healthcare professionals at Coroners\u2019 Inquests.<\/p>"},{"url":"advised-medisec-berkshire-hathaway-european-insurance-dac-in-the-defence-of-medical-negligence-claims-and-advice-on-corporate-and-regulatory-issues","entryTitle":"Advising Medisec\/Berkshire Hathaway European Insurance DAC in the defence of medical negligence claims and advice on corporate and regulatory issues.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising Medisec\/Berkshire Hathaway European Insurance DAC in the defence of medical negligence claims and providing advice on corporate and regulatory issues.<\/p>"},{"url":"advising-the-health-service-executive-and-the-state-claims-agency-regarding-ongoing-product-liability-litigation-against-depuy","entryTitle":"Advising the Health Service Executive and the State Claims Agency regarding ongoing product liability litigation against DePuy.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising the Health Service Executive and the State Claims Agency regarding ongoing product liability litigation against DePuy.<\/p>"},{"url":"advising-the-health-and-information-quality-authority-on-a-number-of-high-profile-statutory-investigations-into-the-care-provided-at-acute-general-and-obstetric-hospitals","entryTitle":"Advising the Health and Information Quality Authority on a number of high-profile statutory investigations into the care provided at acute general and obstetric hospitals.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising the Health and Information Quality Authority on a number of high-profile statutory investigations into the care provided at acute general and obstetric hospitals.<\/p>"},{"url":"advising-a-uk-investor-on-an-irish-investment-screening-notification-concerning-the-acquisition-of-a-pharmaceutical-company-this-was-one-of-the-first-notifications-made-under-irelands-new-screening-regime","entryTitle":"Advising a UK investor on an Irish investment screening notification concerning the acquisition of a pharmaceutical company. This was one of the first notifications made under Ireland\u2019s new screening regime.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a UK investor on an Irish investment screening notification concerning the acquisition of a pharmaceutical company. This was one of the first notifications made under Ireland\u2019s new screening regime.<\/p>"},{"url":"acting-as-standing-counsel-and-advising-a-leading-healthcare-solutions-company-on-irish-and-eu-merger-control-and-irish-investment-screening-considerations-arising-in-the-context-of-m-a-transactions","entryTitle":"Acting as standing counsel and advising a leading healthcare solutions company on Irish and EU merger control and Irish investment screening considerations arising in the context of M&A transactions.","representativeMatterTitle":"","representativeMatterContent":"<p>Acting as standing counsel and advising a leading healthcare solutions company on Irish and EU merger control and Irish investment screening considerations arising in the context of M&A transactions.<\/p>"},{"url":"advising-bertelsmann-on-the-irish-merger-control-aspects-of-its-acquisition-of-medicines-ie","entryTitle":"Advising Bertelsmann on the Irish merger control aspects of its acquisition of Medicines.ie.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising Bertelsmann on the Irish merger control aspects of its acquisition of Medicines.ie.<\/p>"},{"url":"advising-on-irish-merger-control-and-investment-screening-aspects-of-the-sale-of-an-irish-digital-healthcare-provider","entryTitle":"Advising on Irish merger control and investment screening aspects of the sale of an Irish digital healthcare provider.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising on Irish merger control and investment screening aspects of the sale of an Irish digital healthcare provider.<\/p>"},{"url":"advising-a-biopharmaceutical-company-on-the-irish-investment-screening-aspects-of-its-acquisition-of-another-global-pharmaceutical-company","entryTitle":"Advising a biopharmaceutical company on the Irish investment screening aspects of its acquisition of another global pharmaceutical company.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a biopharmaceutical company on the Irish investment screening aspects of its acquisition of another global pharmaceutical company.<\/p>"},{"url":"advising-a-significant-industry-player-in-the-context-of-an-unannounced-dawn-raid-conducted-by-the-european-commission-which-was-assisted-by-the-irish-competition-and-consumer-protection-commission","entryTitle":"Advising a significant industry player in the context of an unannounced dawn raid conducted by the European Commission, which was assisted by the Irish Competition and Consumer Protection Commission.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a significant industry player in the context of an unannounced dawn raid conducted by the European Commission, which was assisted by the Irish Competition and Consumer Protection Commission.<\/p>"},{"url":"acting-as-standing-competition-law-counsel-for-a-branded-pharmaceutical-company-advising-on-dawn-raid-preparedness-and-competitor-collaborations-including-joint-ventures","entryTitle":"Acting as standing competition law counsel for a branded pharmaceutical company advising on dawn raid preparedness and competitor collaborations, including joint ventures.","representativeMatterTitle":"","representativeMatterContent":"<p>Acting as standing competition law counsel for a branded pharmaceutical company advising on dawn raid preparedness and competitor collaborations, including joint ventures.<\/p>"},{"url":"advising-a-leading-diagnostic-information-services-company-on-a-public-procurement-process-undertaken-by-the-hse","entryTitle":"Advising a leading diagnostic information services company on a public procurement process undertaken by the HSE.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a leading diagnostic information services company on a public procurement process undertaken by the HSE.<\/p>"},{"url":"advising-a-leading-retail-pharmacy-chain-on-a-legal-challenge-to-the-direct-award-of-a-concession-contract-to-a-competitor","entryTitle":"Advising a leading retail pharmacy chain on a legal challenge to the direct award of a concession contract to a competitor.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a leading retail pharmacy chain on a legal challenge to the direct award of a concession contract to a competitor. <\/p>"},{"url":"advising-a-global-pharmaceutical-company-on-a-pan-eu-compliance-project-for-nis2","entryTitle":"Advising a global pharmaceutical company on a pan EU-compliance project for NIS2.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global pharmaceutical company on a pan-EU compliance project for NIS2.<\/p>"},{"url":"advising-a-global-alcoholic-beverages-company-on-a-pan-eu-compliance-project-for-nis2","entryTitle":"Advising a global alcoholic beverages company on a pan-EU compliance project for NIS2.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global alcoholic beverages company on a pan-EU compliance project for NIS2.<\/p>"},{"url":"advising-a-clinical-trial-stage-pharmaceutical-company-on-nis2-compliance","entryTitle":"Advising a clinical-trial stage pharmaceutical company on NIS2 compliance.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a pharmaceutical company at clinical-trial stage on NIS2 compliance.<\/p>"},{"url":"advising-an-international-business-on-the-overlap-between-nis2-gdpr-and-the-cyber-resilience-act-and-the-applications-of-these-laws-to-various-products","entryTitle":"Advising an international business on the overlap between NIS2, GDPR and the Cyber Resilience Act and the applications of these laws to various products.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising an international business on the overlap between NIS2, GDPR and the Cyber Resilience Act and the applications of these laws to various products.<\/p>"},{"url":"advising-a-fortune-500-medical-device-manufacturer-on-environmental-claims-relating-to-updated-packaging-designs","entryTitle":"Advising a Fortune 500 medical device manufacturer on environmental claims relating to updated packaging designs.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a Fortune 500 medical device manufacturer on environmental claims relating to updated packaging designs.<\/p>"},{"url":"advising-a-fortune-200-company-on-current-and-upcoming-circular-economy-legal-requirements-for-its-packaging-and-packaged-products","entryTitle":"Advising a Fortune 200 company on current and upcoming circular economy legal requirements for its packaging and packaged products.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a Fortune 200 company on current and upcoming circular economy legal requirements for its packaging and packaged products.<\/p>"},{"url":"acting-for-a-multinational-beverage-company-responding-to-an-advertising-complaint-relating-to-100-green-energy-claims-made-on-product-packaging-and-in-promotional-materials","entryTitle":"Acting for a multinational beverage company responding to an advertising complaint relating to \u201c100% green energy\u201d claims made on product packaging and in promotional materials.","representativeMatterTitle":"","representativeMatterContent":"<p>Acting for a multinational beverage company responding to an advertising complaint relating to \u201c100% green energy\u201d claims made on product packaging and in promotional materials.<\/p>"},{"url":"advising-one-of-the-worlds-largest-chemical-suppliers-on-environmental-regulations-relating-to-water-discharges","entryTitle":"Advising one of the world\u2019s largest chemical suppliers on environmental regulations relating to water discharges.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising one of the world\u2019s largest chemical suppliers on environmental regulations relating to water discharges.<\/p>"},{"url":"advising-a-global-manufacturer-of-medical-devices-for-diabetes-on-compliance-with-the-chemicals-acts-2008-and-2010-restriction-of-certain-hazardous-substances-in-electrical-and-electronic-equipment-directive-reach-regulation-clp-r-2","entryTitle":"Advising a global manufacturer of medical devices for diabetes on compliance with the Chemicals Acts 2008 and 2010, Restriction of Certain Hazardous Substances in Electrical and Electronic Equipment Directive, REACH Regulation, CLP Regulation, and the POP","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global manufacturer of medical devices for diabetes on compliance with the Chemicals Acts 2008 and 2010, Restriction of Certain Hazardous Substances in Electrical and Electronic Equipment Directive, REACH Regulation, CLP Regulation, and the POPs Regulations.<\/p>"},{"url":"advising-biohaven-pharmaceuticals-on-the-irish-law-aspects-of-a-number-of-matters-including-the-sale-of-its-migraine-business-to-pfizer-in-a-transaction-valued-at-11-6-billion","entryTitle":"Advising Biohaven Pharmaceuticals on the Irish law aspects of a number of matters including the sale of its migraine business to Pfizer in a transaction valued at $11.6 billion.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising Biohaven Pharmaceuticals on the Irish law aspects of a number of matters including the sale of its migraine business to Pfizer in a transaction valued at $11.6 billion.<\/p>"},{"url":"advised-on-a-series-of-high-value-distributions-made-by-a-multinational-pharmaceutical-group","entryTitle":"Advised on a series of high value distributions made by a multinational pharmaceutical group.","representativeMatterTitle":"","representativeMatterContent":"<p>Advised on a series of high value distributions made by a multinational pharmaceutical group.<\/p>"},{"url":"providing-company-law-advice-to-a-global-chemicals-supplier","entryTitle":"Providing company law advice to a global chemicals supplier.","representativeMatterTitle":"","representativeMatterContent":"<p>Providing company law advice to a global chemicals supplier.<\/p>"},{"url":"repeat-advice-on-a-series-of-high-value-distributions-made-by-a-multinational-pharmaceutical-group","entryTitle":"Providing repeat advice on a series of high value distributions made by a multinational pharmaceutical group.","representativeMatterTitle":"","representativeMatterContent":"<p>Repeat advice on a series of high value distributions made by a multinational pharmaceutical group.<\/p>"},{"url":"provision-of-compliance-and-ongoing-company-law-services-to-several-leading-multinational-pharmaceutical-groups","entryTitle":"Provision of compliance and ongoing company law services to several leading multinational pharmaceutical groups.","representativeMatterTitle":"","representativeMatterContent":"<p>Provision of compliance and ongoing company law services to several leading multinational pharmaceutical groups.<\/p>"},{"url":"assisting-in-the-statutory-merger-of-companies-holding-orphan-drug-designations","entryTitle":"Assisting in the statutory merger of companies holding orphan drug designations.","representativeMatterTitle":"","representativeMatterContent":"<p>Assisting in the statutory merger of companies holding orphan drug designations.<\/p>"},{"url":"acting-for-neuraxpharm-in-the-defence-of-patent-infringement-proceedings-and-bringing-a-counterclaim-for-invalidity-relating-to-the-launch-of-a-generic-ms-treatment-on-the-irish-market","entryTitle":"Acting for Neuraxpharm in the defence of patent infringement proceedings and bringing a counterclaim for invalidity relating to the launch of a generic MS treatment on the Irish market.","representativeMatterTitle":"","representativeMatterContent":"<p>Acting for Neuraxpharm in the defence of patent infringement proceedings and bringing a counterclaim for invalidity relating to the launch of a generic MS treatment on the Irish market.<\/p>"},{"url":"advising-mckesson-corporation-on-its-acquisition-of-the-pharmaceutical-distribution-business-udg-healthcare-plc-an-irish-ftse-250-company-for-408-million","entryTitle":"Advising McKesson Corporation on its acquisition of the pharmaceutical distribution business, UDG Healthcare plc, an Irish FTSE 250 company, for \u20ac408 million.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising McKesson Corporation on its acquisition of the pharmaceutical distribution business, UDG Healthcare plc, an Irish FTSE 250 company, for \u20ac408 million.<\/p>"},{"url":"providing-eu-regulatory-advice-to-a-global-pharmaceutical-company-relating-to-the-application-of-the-ai-act-to-drug-development-and-clinical-research-activities","entryTitle":"Providing EU regulatory advice to a global pharmaceutical company relating to the application of the AI Act to drug development and clinical research activities.","representativeMatterTitle":"","representativeMatterContent":"<p>Providing EU regulatory advice to a global pharmaceutical company relating to the application of the AI Act to drug development and clinical research activities.<\/p>"},{"url":"advising-a-global-pharmaceutical-company-on-its-partnership-with-a-patient-support-app-regarding-the-administration-of-one-of-its-medicines","entryTitle":"Advising a global pharmaceutical company on its partnership with a patient support app regarding the administration of one of its medicines.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global pharmaceutical company on its partnership with a patient support app regarding the administration of one of its medicines.<\/p>"},{"url":"advising-a-global-pharmaceutical-company-on-its-obligations-under-nis2-throughout-the-eu","entryTitle":"Advising a global pharmaceutical company on its obligations under NIS2 throughout the EU.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global pharmaceutical company on its obligations under NIS2 throughout the EU.<\/p>"},{"url":"acting-for-fresenius-in-patent-infringement-proceedings-regarding-the-launch-of-amgevita-by-amgen","entryTitle":"Acting for Fresenius in patent infringement proceedings regarding the launch of Amgevita\u00ae by Amgen.","representativeMatterTitle":"","representativeMatterContent":"<p>Acting for Fresenius in patent infringement proceedings regarding the launch of Amgevita\u00ae by Amgen.<\/p>"},{"url":"acting-for-teva-pharmaceuticals-industries-limited-in-separate-spc-and-patent-revocation-proceedings-before-the-commercial-court","entryTitle":"Acting for Teva Pharmaceuticals Industries Limited in separate SPC and patent revocation proceedings before the Commercial Court.","representativeMatterTitle":"","representativeMatterContent":"<p>Acting for Teva Pharmaceuticals Industries Limited in separate SPC and patent revocation proceedings before the Commercial Court.<\/p>"},{"url":"advised-nyse-listed-biohaven-pharmaceuticals-on-the-irish-ip-and-tax-law-aspects-of-the-sale-of-the-biohaven-group-companies-that-own-and-commercialise-its-nurtec-and-vysera-products-to-pfizer-for-more-than-11-8-billion","entryTitle":"Advised NYSE-listed Biohaven Pharmaceuticals on the Irish IP and tax law aspects of the sale of the Biohaven group companies that own and commercialise its Nurtec and Vysera products to Pfizer for more than $11.8 billion.","representativeMatterTitle":"","representativeMatterContent":"<p>Advised NYSE-listed Biohaven Pharmaceuticals on the Irish IP and tax law aspects of the sale of the Biohaven group companies that own and commercialise its Nurtec and Vysera products to Pfizer for more than $11.8 billion.<\/p>"},{"url":"acting-for-novartis-pharma-ag-in-dealing-with-high-court-litigation-against-eli-lilly-and-company-eli-lilly-nederland-b-v-and-eli-lilly-kinsale-limited","entryTitle":"Acting for Novartis Pharma AG in dealing with High Court litigation against Eli Lilly and Company, Eli Lilly Nederland B.V. and Eli Lilly Kinsale Limited.","representativeMatterTitle":"","representativeMatterContent":"<p>Acting for Novartis Pharma AG in dealing with High Court litigation against Eli Lilly and Company, Eli Lilly Nederland B.V. and Eli Lilly Kinsale Limited.<\/p>"},{"url":"acting-for-and-advising-arthropharm-europe-limited-on-a-multi-million-euro-pharmaceutical-product-the-subject-of-judicial-review-proceedings-against-the-health-products-regulatory-authority","entryTitle":"Acting for and advising Arthropharm (Europe) Limited on a multi-million-euro pharmaceutical product the subject of judicial review proceedings against the Health Products Regulatory Authority.","representativeMatterTitle":"","representativeMatterContent":"<p>Acting for and advising Arthropharm (Europe) Limited on a multi-million-euro pharmaceutical product the subject of judicial review proceedings against the Health Products Regulatory Authority.<\/p>"},{"url":"advising-west-pharmaceutical-services-on-the-procurement-and-fast-tracked-completion-of-the-design-and-construction-of-a-substantial-new-pharma-manufacturing-facility-in-dublin","entryTitle":"Advising West Pharmaceutical Services on the procurement and fast-tracked completion of the design and construction of a substantial new pharma manufacturing facility in Dublin.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising West Pharmaceutical Services on the procurement and fast-tracked completion of the design and construction of a substantial new pharma manufacturing facility in Dublin.<\/p>"},{"url":"advising-fitbit-llc-now-google-llc-on-the-ce-marking-of-software-medical-devices-under-the-mdr","entryTitle":"Advising Fitbit LLC (now Google LLC) on the CE marking of software medical devices under the MDR.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising Fitbit LLC (now Google LLC) on the CE marking of software medical devices under the Medical Devices Regulation (MDR).<\/p>"},{"url":"advising-google-llc-on-its-regulatory-roadmap-and-approval-process-for-its-groundbreaking-loss-of-pulse-detection-feature","entryTitle":"Advising Google LLC on its regulatory roadmap and approval process for its groundbreaking Loss of Pulse Detection feature.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising Google LLC on its regulatory roadmap and approval process for its groundbreaking <em>Loss of Pulse Detection<\/em> feature.<\/p>"},{"url":"advising-a-baby-wearable-monitor-manufacturer-through-an-investigation-by-regulators-on-product-classification-and-regarding-the-potential-withdrawal-of-its-product-from-eu-markets","entryTitle":"Advising a baby wearable monitor manufacturer through an investigation by regulators on product classification and regarding the potential withdrawal of its product from EU markets.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a baby wearable monitor manufacturer through an investigation by regulators on product classification and regarding the potential withdrawal of its product from EU markets.<\/p>"},{"url":"providing-advice-to-various-providers-of-digital-health-and-telemedicine-platforms-on-irish-regulations-governing-online-medical-consultations-and-prescription-medicines","entryTitle":"Advising various providers of digital health and telemedicine platforms on Irish regulations governing online medical consultations and prescription medicines.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising various providers of digital health and telemedicine platforms on Irish regulations governing online medical consultations and prescription medicines.<\/p>"},{"url":"advising-letsgetchecked-on-its-home-test-kit-and-telemedicine-services","entryTitle":"Advising LetsGetChecked on its home test kit and telemedicine services.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising LetsGetChecked on its home test kit and telemedicine services.<\/p>"},{"url":"advising-a-global-medical-device-manufacturer-on-their-ai-act-compliance","entryTitle":"Advising a global medical device manufacturer on their AI Act compliance.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global medical device manufacturer on their AI Act compliance.<\/p>"},{"url":"advising-a-digital-health-company-developing-a-vr-enabled-mental-health-app-on-its-classification-as-a-software-medical-device-and-requirements-under-eu-medical-device-frameworks","entryTitle":"Advising a digital health company developing a VR-enabled mental health app on its classification as a software medical device and requirements under EU medical device frameworks.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a digital health company developing a VR-enabled mental health app on its classification as a software medical device and requirements under EU medical device frameworks.<\/p>"},{"url":"advising-a-global-cosmetics-company-on-trade-mark-issues-relating-to-its-expansion-in-the-eu-including-acting-in-trademark-opposition-proceedings","entryTitle":"Advising a global cosmetics company on trade mark issues relating to its expansion in the EU, including acting in trademark opposition proceedings.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global cosmetics company on trade mark issues relating to its expansion in the EU, including acting in trademark opposition proceedings.<\/p>"},{"url":"advising-a-global-haircare-company-on-its-obligations-post-brexit-concerning-establishment-and-responsible-person-appointment","entryTitle":"Advising a global haircare company on its obligations post Brexit concerning establishment and responsible person appointment.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global haircare company on its obligations post Brexit concerning establishment and responsible person appointment.<\/p>"},{"url":"advising-a-global-cosmetics-company-on-the-defence-of-product-liability-proceedings","entryTitle":"Advising a global cosmetics company on the defence of product liability proceedings.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global cosmetics company on the defence of product liability proceedings.<\/p>"},{"url":"defending-a-criminal-prosecution-against-a-global-cosmetics-company-for-alleged-breaches-of-consumer-protection-legislation","entryTitle":"Defending a criminal prosecution brought against a global cosmetics company for alleged breaches of consumer protection legislation.","representativeMatterTitle":"","representativeMatterContent":"<p>Defending a criminal prosecution brought against a global cosmetics company for alleged breaches of consumer protection legislation.<\/p>"},{"url":"advising-a-global-manufacturer-on-the-potential-re-classification-of-substances-used-in-their-products-under-the-reach-regulation-and-advising-on-actions-required-under-the-eu-cosmetics-regulations","entryTitle":"Advising a global manufacturer on the potential re-classification of substances used in their products under the REACH Regulation, and advising on actions required under the EU Cosmetics Regulations.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global manufacturer on the potential re-classification of substances used in their products under the REACH Regulation, and advising on actions required under the EU Cosmetics Regulations.<\/p>"},{"url":"defending-a-global-cosmetics-manufacturer-in-various-product-liability-claims","entryTitle":"Defending a global cosmetics manufacturer in various product liability claims.","representativeMatterTitle":"","representativeMatterContent":"<p>Defending a global cosmetics manufacturer in various product liability claims.<\/p>"},{"url":"advised-an-irish-producer-of-artisanal-foods-in-a-pricing-dispute-with-an-italian-supplier","entryTitle":"Advised an Irish producer of artisanal foods in a pricing dispute with an Italian supplier.","representativeMatterTitle":"","representativeMatterContent":"<p>Advised an Irish producer of artisanal foods in a pricing dispute with an Italian supplier.<\/p>"},{"url":"advised-boyne-valley-group-on-the-management-of-their-trade-mark-portfolio-including-brands-such-as-chivers-don-carlos-killeen-boyne-valley-honey-and-mcdonnells","entryTitle":"Advised Boyne Valley Group on the management of their trade mark portfolio, including brands such as Chivers, Don Carlos, Killeen, Boyne Valley Honey, and McDonnells.","representativeMatterTitle":"","representativeMatterContent":"<p>Advised Boyne Valley Group on the management of their trade mark portfolio, including brands such as Chivers, Don Carlos, Killeen, Boyne Valley Honey, and McDonnells.<\/p>"},{"url":"supporting-a-food-supplement-company-in-its-engagement-with-food-safety-regulators-on-various-cbd-products","entryTitle":"Supporting a food supplement company in its engagement with food safety regulators on various CBD products.","representativeMatterTitle":"","representativeMatterContent":"<p>Supporting a food supplement company in its engagement with food safety regulators on various CBD products.<\/p>"},{"url":"advising-a-global-high-street-chain-on-the-application-of-packaging-requirements-and-the-use-of-chemicals-in-products","entryTitle":"Advising a global high street chain on the application of packaging requirements and the use of chemicals in products.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global high street chain on the application of packaging requirements and the use of chemicals in products.<\/p>"},{"url":"advising-a-us-compliance-solutions-company-on-extended-producer-responsibility-requirements-for-batteries-electrical-equipment-single-use-plastics-packaging-drinks-bottles-and-cans","entryTitle":"Advising a US compliance solutions company on extended producer responsibility requirements for batteries, electrical equipment, single use plastics, packaging, drinks bottles and cans.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a US compliance solutions company on extended producer responsibility requirements for batteries, electrical equipment, single use plastics, packaging, drinks bottles and cans.<\/p>"},{"url":"advising-various-food-businesses-engaging-with-regulators-on-labelling-and-eu-importer-requirements","entryTitle":"Advising various food businesses engaging with regulators on labelling and EU importer requirements.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising various food businesses engaging with regulators on labelling and EU importer requirements.<\/p>"},{"url":"advising-a-leading-irish-food-company-on-trade-mark-infringement-claims-regarding-labelling-for-a-new-product","entryTitle":"Advising a leading Irish food company on trade mark infringement claims regarding labelling for a new product.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a leading Irish food company on trade mark infringement claims regarding labelling for a new product.<\/p>"},{"url":"assisting-a-global-drinks-company-with-its-trade-mark-portfolio-as-well-as-packaging-labelling-and-licensing-compliance","entryTitle":"Assisting a global drinks company with its trade mark portfolio as well as packaging, labelling and licensing compliance.","representativeMatterTitle":"","representativeMatterContent":"<p>Assisting a global drinks company with its trade mark portfolio as well as packaging, labelling and licensing compliance.<\/p>"},{"url":"acting-for-noreside-construction-against-irish-asphalt-in-the-irish-supreme-court-in-pyrite-litigation","entryTitle":"Acting for Noreside Construction against Irish Asphalt in the Irish Supreme Court in pyrite litigation.","representativeMatterTitle":"","representativeMatterContent":"<p>Acting for Noreside Construction against Irish Asphalt in the Irish Supreme Court in pyrite litigation.<\/p>"},{"url":"advising-one-of-the-worlds-largest-chemical-suppliers-on-a-water-connection-agreement-and-development-agreement","entryTitle":"Advising one of the world\u2019s largest chemical suppliers on a water connection agreement and development agreement.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising one of the world\u2019s largest chemical suppliers on a water connection agreement and development agreement.<\/p>"},{"url":"acting-for-the-insurers-of-murphy-concrete-defending-over-200-individual-high-court-actions-for-defective-foundation-materials","entryTitle":"Acting for the insurers of Murphy Concrete defending over 200 individual High Court actions for defective foundation materials.","representativeMatterTitle":"","representativeMatterContent":"<p>Acting for the insurers of Murphy Concrete defending over 200 individual High Court actions for defective foundation materials.<\/p>"},{"url":"advising-a-global-manufacturer-of-medical-devices-for-diabetes-on-compliance-with-the-chemicals-acts-2008-and-2010-restriction-of-certain-hazardous-substances-in-electrical-and-electronic-equipment-directive-reach-regulation-clp-reg","entryTitle":"Advising a global manufacturer of medical devices for diabetes on compliance with the Chemicals Acts 2008 and 2010 Restriction of Certain Hazardous Substances in Electrical and Electronic Equipment Directive, REACH Regulation, CLP Regulation, and the POPs","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a global manufacturer of medical devices for diabetes on compliance with the Chemicals Acts 2008 and 2010 Restriction of Certain Hazardous Substances in Electrical and Electronic Equipment Directive, REACH Regulation, CLP Regulation, and the POPs Regulations.<\/p>"},{"url":"providing-corporate-governance-advice-to-a-global-chemicals-supplier","entryTitle":"Providing corporate governance advice to a global chemicals supplier.","representativeMatterTitle":"","representativeMatterContent":"<p>Providing corporate governance advice to a global chemical supplier.<\/p>"},{"url":"advising-an-irish-based-company-on-the-implications-for-its-reach-registration-as-part-of-a-tax-restructuring-process","entryTitle":"Advising an Irish based company on the implications for its REACH registration as part of a tax restructuring process.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising an Irish-based company on the implications for its REACH registration as part of a tax restructuring process.<\/p>"},{"url":"advising-a-fuel-and-logistics-company-on-being-established-in-ireland-for-the-purposes-of-holding-of-a-reach-registration","entryTitle":"Advising a fuel and logistics company on being \u201cestablished\u201d in Ireland for the purposes of holding of a REACH registration.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising a fuel and logistics company on being \u201cestablished\u201d in Ireland for the purposes of holding of a REACH registration.<\/p>"},{"url":"advising-one-of-the-worlds-largest-chemical-suppliers-on-a-supply-chain-dispute","entryTitle":"Advising one of the world\u2019s largest chemical suppliers on a supply chain dispute.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising one of the world\u2019s largest chemical suppliers on a supply chain dispute.<\/p>"},{"url":"advising-x-on-blah","entryTitle":"Advising X on blah.","representativeMatterTitle":"","representativeMatterContent":"<p>Advising X on blah. <\/p>"}]